The Neurobiology of LRRK2 and its Role in the Pathogenesis of Parkinson’s Disease
- 1 June 2013
- journal article
- review article
- Published by Springer Nature in Neurochemical Research
- Vol. 39 (3) , 576-592
Abstract
Leucine-rich repeat kinase 2 (LRRK2) is a large, widely expressed protein of largely unknown function. Mutations in the gene encoding LRRK2 have been linked to multiple diseases, including a prominent association with familial and sporadic Parkinson’s disease (PD), as well as inflammatory bowel disorders such as Crohn’s disease. The LRRK2 protein possesses both kinase and GTPase signaling domains, as well as multiple protein interaction domains. Experimental studies in both cellular and in vivo models of mutant LRRK2-induced neurodegeneration have given clues to potential function(s) of LRRK2, yet much remains unknown. For example, while it is known that intact kinase and GTPase activity are required for mutant forms of the protein to trigger cell death, the specific targets of these enzymatic activities that mediate the death of neurons are not known. In this review, we discuss the evidence linking LRRK2 to various cellular/neuronal activities such as extrinsic death and inflammatory signaling, lysosomal protein degradation, the cytoskeletal system and neurite outgrowth, vesicle trafficking, mitochondrial dysfunction, as well as multiple points of interaction with several other genes linked to the pathogenesis of PD. In order for more effective therapeutic strategies to be envisioned and implemented, the mechanisms underlying LRRK2-mediated neurodegeneration need to be better characterized. Furthermore, insights into LRRK2-associated PD pathogenesis can potentially advance our understanding of the more common sporadic forms of PD.Keywords
This publication has 137 references indexed in Scilit:
- Number and Brightness Analysis of LRRK2 Oligomerization in Live CellsBiophysical Journal, 2012
- Autophosphorylation in the Leucine-Rich Repeat Kinase 2 (LRRK2) GTPase Domain Modifies Kinase and GTP-Binding ActivitiesJournal of Molecular Biology, 2011
- Inhibition of cyclin‐dependent kinase 5 but not of glycogen synthase kinase 3‐β prevents neurite retraction and tau hyperphosphorylation caused by secretable products of human T‐cell leukemia virus type I‐infected lymphocytesJournal of Neuroscience Research, 2011
- Parkinson’s disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structuresJournal of Neural Transmission, 2011
- Adult neurogenesis and neurite outgrowth are impaired in LRRK2 G2019S miceNeurobiology of Disease, 2011
- Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic miceNeurobiology of Disease, 2010
- Leucine-rich repeat kinase 2 induces α-synuclein expression via the extracellular signal-regulated kinase pathwayCellular Signalling, 2010
- Leucine-Rich Repeat Kinase 2 Regulates the Progression of Neuropathology Induced by Parkinson's-Disease-Related Mutant α-synucleinNeuron, 2009
- The Parkinson’s disease kinase LRRK2 autophosphorylates its GTPase domain at multiple sitesBiochemical and Biophysical Research Communications, 2009
- The R1441C mutation of LRRK2 disrupts GTP hydrolysisBiochemical and Biophysical Research Communications, 2007